A novel biomarker panel for irritable bowel syndrome and the application in the general population

Biological markers that measure gut health and diagnose functional gastro-intestinal (GI) disorders, such as irritable bowel syndrome (IBS), are lacking. The objective was to identify and validate a biomarker panel associated with the pathophysiology of IBS that discriminates IBS from healthy contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mujagic, Zlatan, Tigchelaar, Ettje F., Zhernakova, Alexandra, Ludwig, Thomas, Ramiro-Garcia, Javier, Baranska, Agnieszka, Swertz, Morris A., Masclee, Ad A. M., Wijmenga, Cisca, van Schooten, Frederik J., Smolinska, Agnieszka, Jonkers, Daisy M. A. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893613/
https://www.ncbi.nlm.nih.gov/pubmed/27263852
http://dx.doi.org/10.1038/srep26420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893613/
https://www.ncbi.nlm.nih.gov/pubmed/27263852
http://dx.doi.org/10.1038/srep26420

Ejemplares similares